Amphiphilic nanogels: influence of surface hydrophobicity on protein corona, biocompatibility and cellular uptake

References

• Klinger D, Landfester K. Stimuli-responsive microgels for the loading and release of functional compounds: fundamental concepts and applications. Polymer. 2012;53(23):5209–5231. doi:10.1016/j.polymer.2012.08.053
   Web of Science ®Google Scholar
• Huh AJ, Kwon YJ. “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release. 2011;156(2):128–145. doi:10.1016/j.jconrel.2011.07.00221763369
   PubMed Web of Science ®Google Scholar
• Kar M, Fechner L, Nagel G, Glitscher E, Noe Rimondino G, Calderón M. Chapter 12 responsive nanogels for anti-cancer therapy In: Vashist A, Kaushik AK, Ahmad S, Nair M, editors. Nanogels for Biomedical Applications. London: The Royal Society of Chemistry; 2018:210–260. doi:10.1039/9781788010481
   Google Scholar
• Molina M, Asadian-Birjand M, Balach J, Bergueiro J, Miceli E, Calderón M. Stimuli-responsive nanogel composites and their application in nanomedicine. Chem Soc Rev. 2015;44(17):6161–6186.26505057
   PubMed Web of Science ®Google Scholar
• Molina M, Wedepohl S, Miceli E, Calderon M. Overcoming drug resistance with on-demand charged thermoresponsive dendritic nanogels. Nanomedicine (Lond). 2017;12(2):117–129. doi:10.2217/nnm-2016-030827879151
   PubMedGoogle Scholar
• Shatsberg Z, Zhang X, Ofek P, et al. Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy. J Control Release. 2016;239:159–168. doi:10.1016/j.jconrel.2016.08.02927569663
   PubMed Web of Science ®Google Scholar
• Guo B, Zhao J, Wu C, et al. One-pot synthesis of polypyrrole nanoparticles with tunable photothermal conversion and drug loading capacity. Colloids Surf B Biointerfaces. 2019;177:346–355. doi:10.1016/j.colsurfb.2019.02.01630772669
   PubMedGoogle Scholar
• Wu C, Zhao J, Hu F, et al. Design of injectable agar-based composite hydrogel for multi-mode tumor therapy. Carbohydr Polym. 2018;180:112–121. doi:10.1016/j.carbpol.2017.10.02429103486
   PubMed Web of Science ®Google Scholar
• Schulte B, Rahimi K, Keul H, Demco DE, Walther A, Möller M. Blending of reactive prepolymers to control the morphology and polarity of polyglycidol based microgels. Soft Matter. 2015;11(5):943–953. doi:10.1039/c4sm02116a25515704
   PubMedGoogle Scholar
• Tiwari R, Heuser T, Weyandt E, Wang B, Walther A. Polyacid microgels with adaptive hydrophobic pockets and ampholytic character: synthesis, solution properties and insights into internal nanostructure by cryogenic-TEM. Soft Matter. 2015;11(42):8342–8353. doi:10.1039/c5sm01327e26350118
   PubMedGoogle Scholar
• Wischke C, Kruger A, Roch T, et al. Endothelial cell response to (co)polymer nanoparticles depending on the inflammatory environment and comonomer ratio. Eur J Pharm Biopharm. 2013;84(2):288–296. doi:10.1016/j.ejpb.2013.01.02523429231
   PubMedGoogle Scholar
• Gruber A, Işık D, Fontanezi BB, Böttcher C, Schäfer-Korting M, Klinger D. A versatile synthetic platform for amphiphilic nanogels with tunable hydrophobicity. Polym Chem. 2018;9(47):5572–5584. doi:10.1039/C8PY01123K
   Web of Science ®Google Scholar
• Simon J, Wolf T, Klein K, Landfester K, Wurm FR, Mailander V. Hydrophilicity regulates the stealth properties of polyphosphoester-coated nanocarriers. Angew Chem Int Ed Engl. 2018;57(19):5548–5553. doi:10.1002/anie.20180027229479798
   PubMed Web of Science ®Google Scholar
• Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev. 2009;61(6):428–437. doi:10.1016/j.addr.2009.03.00919376175
   PubMed Web of Science ®Google Scholar
• Cedervall T, Lynch I, Foy M, et al. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl. 2007;46(30):5754–5756. doi:10.1002/anie.20070046517591736
   PubMed Web of Science ®Google Scholar
• Cedervall T, Lynch I, Lindman S, et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A. 2007;104(7):2050–2055. doi:10.1073/pnas.060858210417267609
   PubMed Web of Science ®Google Scholar
• Gessner A, Waicz R, Lieske A, Paulke BR, Mäder K, Müller RH. Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption. Int J Pharm. 2000;196(2):245–249.10699728
   PubMed Web of Science ®Google Scholar
• Lindman S, Lynch I, Thulin E, Nilsson H, Dawson KA, Linse S. Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity. Nano Lett. 2007;7(4):914–920. doi:10.1021/nl062743+17335269
   PubMed Web of Science ®Google Scholar
• Luck M, Paulke BR, Schroder W, Blunk T, Muller RH. Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics. J Biomed Mater Res. 1998;39(3):478–485.9468059
   PubMed Web of Science ®Google Scholar
• Pearson RM, Juettner VV, Hong S. Biomolecular corona on nanoparticles: a survey of recent literature and its implications in targeted drug delivery. Front Chem. 2014;2:108. doi:10.3389/fchem.2014.0010825506050
   PubMed Web of Science ®Google Scholar
• Strojan K, Leonardi A, Bregar VB, Krizaj I, Svete J, Pavlin M. Dispersion of nanoparticles in different media importantly determines the composition of their protein corona. PLoS One. 2017;12(1):e0169552. doi:10.1371/journal.pone.016955228052135
   PubMedGoogle Scholar
• Jones SW, Roberts RA, Robbins GR, et al. Nanoparticle clearance is governed by Th1/Th2 immunity and strain background. J Clin Invest. 2013;123(7):3061–3073. doi:10.1172/JCI6689523778144
   PubMed Web of Science ®Google Scholar
• Oh N, Park JH. Endocytosis and exocytosis of nanoparticles in mammalian cells. Int J Nanomedicine. 2014;9(Suppl 1):51–63. doi:10.2147/IJN.S2659224872703
   PubMed Web of Science ®Google Scholar
• Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307(1):93–102. doi:10.1016/j.ijpharm.2005.10.01016303268
   PubMed Web of Science ®Google Scholar
• Schottler S, Landfester K, Mailander V. Controlling the stealth effect of nanocarriers through understanding the protein corona. Angew Chem Int Ed Engl. 2016;55(31):8806–8815. doi:10.1002/anie.20160223327303916
   PubMed Web of Science ®Google Scholar
• Allen TM, Hansen CB, de Menezes DEL. Pharmacokinetics of long-circulating liposomes. Adv Drug Deliv Rev. 1995;16(2):267–284. doi:10.1016/0169-409X(95)00029-7
   Web of Science ®Google Scholar
• Amoozgar Z, Yeo Y. Recent advances in stealth coating of nanoparticle drug delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012;4(2):219–233. doi:10.1002/wnan.115722231928
   PubMed Web of Science ®Google Scholar
• Essa S, Rabanel JM, Hildgen P. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density. Int J Pharm. 2011;411(1–2):178–187. doi:10.1016/j.ijpharm.2011.02.03921458551
   PubMed Web of Science ®Google Scholar
• Reddy KR, Wright TL, Pockros PJ, et al. Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C. Hepatology (Baltimore, Md). 2001;33(2):433–438. doi:10.1053/jhep.2001.21747
   PubMed Web of Science ®Google Scholar
• García-Álvarez R, Hadjidemetriou M, Sánchez-Iglesias A, Liz-Marzán LM, Kostarelos K. In vivo formation of protein corona on gold nanoparticles. The effect of their size and shape. Nanoscale. 2018;10(3):1256–1264. doi:10.1039/c7nr08322j29292433
   PubMed Web of Science ®Google Scholar
• Lundqvist M, Augustsson C, Lilja M, et al. The nanoparticle protein corona formed in human blood or human blood fractions. PLoS One. 2017;12(4):e0175871. doi:10.1371/journal.pone.017587128414772
   PubMed Web of Science ®Google Scholar
• Rahman M, Laurent S, Tawil N, Yahia LH, Mahmoudi M. Nanoparticle and protein corona In: Protein-Nanoparticle Interactions: The Bio-Nano Interface. Berlin, Heidelberg: Springer Berlin Heidelberg; 2013:21–44.
   Google Scholar
• Fleischmann C, Gopez J, Lundberg P, et al. A robust platform for functional microgels via thiol-ene achemistry with reactive polyether-based nanoparticles. Polym Chem. 2015;6(11):2029–2037. doi:10.1039/C4PY01766H26005499
   PubMedGoogle Scholar
• Silva JC, Denny R, Dorschel C, et al. Simultaneous qualitative and quantitative analysis of the Escherichia coli proteome: a sweet tale. Mol Cell Proteomics. 2006;5(4):589–607. doi:10.1074/mcp.M500321-MCP20016399765
   PubMedGoogle Scholar
• Silva JC, Gorenstein MV, Li GZ, Vissers JP, Geromanos SJ. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol Cell Proteomics. 2006;5(1):144–156. doi:10.1074/mcp.M500230-MCP20016219938
   PubMed Web of Science ®Google Scholar
• Blazejewski J-C, Hofstraat JW, Lequesne C, Wakselman C, Wiersum UE. Formation of monomeric halogenoaryl acrylates in the presence of hindered pyridine bases. J Fluor Chem. 1998;91(2):175–177. doi:10.1016/S0022-1139(98)00222-X
   Web of Science ®Google Scholar
• Eberhardt M, Mruk R, Zentel R, Theato P. Synthesis of Pentafluorophenyl(meth)acrylate Polymers: New Precursor Polymers for the Synthesis of Multifunctional Materials. European Polymer Journal 2005;41(7):1569–1575. doi:10.1016/j.eurpolymj.2005.01.025
   Google Scholar
• Eberhardt M, Théato P. RAFT polymerization of pentafluorophenyl methacrylate: preparation of reactive linear diblock copolymers. Macromol Rapid Commun. 2005;26(18):1488–1493. doi:10.1002/(ISSN)1521-3927
   Web of Science ®Google Scholar
• Kearns MD, Donkor AM, Savva M. Structure-transfection activity studies of novel cationic cholesterol-based amphiphiles. Mol Pharm. 2008;5(1):128–139. doi:10.1021/mp700131c18159927
   PubMedGoogle Scholar
• Nie Y, Gunther M, Gu Z, Wagner E. Pyridylhydrazone-based PEGylation for pH-reversible lipopolyplex shielding. Biomaterials. 2011;32(3):858–869. doi:10.1016/j.biomaterials.2010.09.03221030074
   PubMed Web of Science ®Google Scholar
• Gentsch R, Pippig F, Nilles K, et al. Modular approach toward bioactive fiber meshes carrying oligosaccharides. Macromolecules. 2010;43(22):9239–9247. doi:10.1021/ma101607a
   Web of Science ®Google Scholar
• Gibson MI, Fröhlich E, Klok H-A. Postpolymerization modification of poly(pentafluorophenyl methacrylate): synthesis of a diverse water-soluble polymer library. J Polym Sci A Polym Chem. 2009;47(17):4332–4345. doi:10.1002/pola.v47:17
   Web of Science ®Google Scholar
• Rabilloud T, Strub J-M, Luche S, Girardet JL, van Dorsselaer A, Lunardi J. Ruthenium II tris (bathophenanthroline disulfonate), a powerful fluorescent stain for detection of proteins in gel with minimal interference in subsequent mass spectrometry analysis. Proteome. 2000;1(1):1–14. doi:10.1007/s102160000002
   Google Scholar
• Rappsilber J, Ishihama Y, Mann M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal Chem. 2003;75(3):663–670. doi:10.1021/ac026117i12585499
   PubMed Web of Science ®Google Scholar
• Staufenbiel S, Merino M, Li W, et al. Surface characterization and protein interaction of a series of model poly[acrylonitrile-co-(N-vinyl pyrrolidone)] nanocarriers for drug targeting. Int J Pharm. 2015;485(1–2):87–96. doi:10.1016/j.ijpharm.2015.02.07225746947
   PubMedGoogle Scholar
• Walkey CD, Chan WC. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev. 2012;41(7):2780–2799. doi:10.1039/c1cs15233e22086677
   PubMed Web of Science ®Google Scholar
• Lammers T, Ulbrich K. HPMA copolymers: 30 years of advances. Adv Drug Deliv Rev. 2010;62(2):119–121. doi:10.1016/j.addr.2009.12.004
   PubMed Web of Science ®Google Scholar
• Salvati A, Nelissen I, Haase A, et al. Quantitative measurement of nanoparticle uptake by flow cytometry illustrated by an interlaboratory comparison of the uptake of labelled polystyrene nanoparticles. NanoImpact. 2018;9:42–50. doi:10.1016/j.impact.2017.10.004
   Web of Science ®Google Scholar
• Lee K, Yu Y. Lipid bilayer disruption induced by amphiphilic Janus nanoparticles: the non-monotonic effect of charged lipids. Soft Matter. 2019. doi:10.1039/C8SM02525H
   Web of Science ®Google Scholar
• Jones MC, Jones SA, Riffo-Vasquez Y, et al. Quantitative assessment of nanoparticle surface hydrophobicity and its influence on pulmonary biocompatibility. J Control Release. 2014;183:94–104. doi:10.1016/j.jconrel.2014.03.02224657808
   PubMed Web of Science ®Google Scholar
• Li Y, Chen X, Gu N. Computational investigation of interaction between nanoparticles and membranes: hydrophobic/hydrophilic effect. J Phys Chem B. 2008;112(51):16647–16653. doi:10.1021/jp805190619032046
   PubMed Web of Science ®Google Scholar
• Ong KJ, MacCormack TJ, Clark RJ, et al. Widespread nanoparticle-assay interference: implications for nanotoxicity testing. PLoS One. 2014;9(3):e90650. doi:10.1371/journal.pone.009065024618833
   PubMed Web of Science ®Google Scholar
• Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA. What the cell “sees” in bionanoscience. J Am Chem Soc. 2010;132(16):5761–5768. doi:10.1021/ja910675v20356039
   PubMed Web of Science ®Google Scholar
• Gunawan C, Lim M, Marquis CP, Amal R. Nanoparticle–protein corona complexes govern the biological fates and functions of nanoparticles. J Mater Chem B. 2014;2(15):2060–2083. doi:10.1039/c3tb21526a
   PubMed Web of Science ®Google Scholar
• Jo DH, Kim JH, Lee TG, Kim JH. Size, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseases. Nanomedicine. 2015;11(7):1603–1611. doi:10.1016/j.nano.2015.04.01525989200
   PubMed Web of Science ®Google Scholar
• Corbo C, Molinaro R, Parodi A, Toledano Furman NE, Salvatore F, Tasciotti E. The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. Nanomedicine (Lond). 2016;11(1):81–100. doi:10.2217/nnm.15.18826653875
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm. 2008;5(4):487–495. doi:10.1021/mp800032f18510338
   PubMed Web of Science ®Google Scholar
• Du Clos TW. Pentraxins: structure, function, and role in inflammation. ISRN Inflamm. 2013;2013:379040. doi:10.1155/2013/37904024167754
   PubMedGoogle Scholar
• Roversi P, Johnson S, Caesar JJ, et al. Structural basis for complement factor I control and its disease-associated sequence polymorphisms. Proc Natl Acad Sci U S A. 2011;108(31):12839–12844. doi:10.1073/pnas.110216710821768352
   PubMed Web of Science ®Google Scholar
• Schwaeble WJ, Ali YM, Sim RB. Chapter 15 - the roles and contributions of the complement system in the pathophysiology of autoimmune diseases A2 - rose, noel R In: Mackay IR, editor. The Autoimmune Diseases. 5th ed. Boston: Academic Press; 2014:217–227.
   Google Scholar